HIV disease
Clinical research is centered on HIV-1 infection, with interest in maintaining viral suppression and supporting treatment strategies for people living with HIV.
- Antiretroviral therapy
- Virological suppression
- HIV treatment simplification
The sponsor’s work reflects a focus on treatment approaches for patients already controlled on ART, with attention to durable control of viral replication and ongoing management of chronic infection.
Antiviral treatment combinations
Research activity includes evaluation of dual therapy strategies in antiretroviral medicine, particularly combinations designed to preserve efficacy while reducing treatment burden.
- Doravirine
- Raltegravir
- Combination antiretroviral regimens
Interest extends to regimen design for suppressed patients requiring long-term maintenance therapy in infectious diseases.
Infectious diseases and tropical medicine
The sponsor is based within a research environment focused on infectious pathologies, including tropical diseases and HIV/AIDS, with clinical activity aligned to specialized care in these fields.
- Infectious pathology
- Tropical medicine
- HIV/AIDS care
Its clinical interests are situated at the intersection of virology and specialized infectious disease management.
